Catalyst Pharmaceuticals Inc (CPRX)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 71,410 62,037 115,549 99,406 83,079 66,917 54,498 45,060 39,482 41,610 74,621 72,220 74,983 71,476 41,766 42,946 31,875 9,445 -12,024 -28,949
Total assets US$ in thousands 470,114 413,211 443,896 407,227 375,630 333,114 267,309 246,972 237,788 223,248 209,130 197,216 192,354 174,860 131,412 117,880 112,376 96,691 78,234 61,077
ROA 15.19% 15.01% 26.03% 24.41% 22.12% 20.09% 20.39% 18.24% 16.60% 18.64% 35.68% 36.62% 38.98% 40.88% 31.78% 36.43% 28.36% 9.77% -15.37% -47.40%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $71,410K ÷ $470,114K
= 15.19%

The return on assets (ROA) for Catalyst Pharmaceuticals Inc has shown a fluctuating trend over the past few quarters.

In the most recent quarter, the ROA stood at 15.19%, reflecting the company's ability to generate a profit relative to its total assets. Looking at the trend, we can observe that the ROA has generally been on an upward trajectory since the beginning of 2021 when it was 9.77%. The ROA peaked in the second quarter of 2021 at an impressive 40.88%, indicating a strong performance during that period.

The ROA then experienced a slight dip in the following quarters but remained at relatively healthy levels. Notably, in the second quarter of 2022 and the third quarter of 2022, the ROA rose above 20%, suggesting efficient asset utilization and profitability.

It's essential to highlight the significant improvement in ROA compared to the last three quarters of 2019 and 2020, where the company had negative ROA figures, indicating operational inefficiencies and potentially poor financial performance during that period.

Overall, the recent ROA figures demonstrate that Catalyst Pharmaceuticals Inc has been effectively managing its assets to generate profits, with the most recent quarters showing continued stability with ROA figures ranging from 15.01% to 26.03%.


Peer comparison

Dec 31, 2023